Cipla concludes transfer of its entire stake in Biomab

25 Jan 2016 Evaluate

Cipla has completed the transfer formalities in relation to the divestment of its entire 25% stake held in Biomab Holding, Hong Kong (Biomab) on January 22, 2016. Consequently, the company ceases to hold any stake in Biomab.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.


Cipla Share Price

1366.50 -11.35 (-0.82%)
21-Jan-2026 14:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1614.85
Dr. Reddys Lab 1152.10
Cipla 1366.50
Zydus Lifesciences 871.25
Lupin 2134.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×